Successful reduced-intensity stem cell transplantation with cord blood for a poor-prognosis adult with refractory chronic active Epstein-Barr virus infection

International Journal of Hematology

Volumn 85, Issue 5, 2007, Pages 443-445

  Nakagawa, Masao ^a   Hashino, Satoshi ^a   Takahata, Mutsumi ^a   Kawamura, Takahito ^a   Fujisawa, Fumie ^a   Kahata, Kaoru ^a   Kondo, Takeshi ^a   Imamura, Masahiro ^a   Ando, Sachiko ^b   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEINE KEIJINKAI HOSPITAL   (Japan)

Author keywords

Chronic active Epstein Barr virus infection; Cord blood; Epstein Barr virus; Reduced intensity stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PIRARUBICIN; PREDNISOLONE; RANIMUSTINE; TACROLIMUS; VIDARABINE; VINCRISTINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CORD BLOOD STEM CELL TRANSPLANTATION; COUGHING; CRYOPRESERVATION; DRUG MEGADOSE; EDEMA; EPSTEIN BARR VIRUS; FEMALE; FEVER; FLUORESCENCE ACTIVATED CELL SORTING; HEPATOSPLENOMEGALY; HUMAN; LYMPHADENOPATHY; MULTIPLE CYCLE TREATMENT; NEPHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEURA EFFUSION; PROGNOSIS; REDUCED INTENSITY CONDITIONING; REMISSION; SYMPTOM; VIRUS INFECTION; CHRONIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED;

CHRONIC DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; TRANSPLANTATION CONDITIONING;

EID: 34548450765     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.06115     Document Type: Article

References (10)

1. Straus SE. The chronic mononucleosis syndrome. J Infect Dis. 1988;157:405-412.
2. Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80:64-69.
3. Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187:527-533.
4. Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Crit Rev Oncol Hematol. 2002;44:251-257.
5. Kimura H, Tsuge I, Imai S, et al. Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection. Med Microbiol Immunol. 1995;184:63-68.
6. Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J Med Virol. 2001;64:141-148.
7. Ishimura M, Ohga S, Nomura A, et al. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation. Am J Hematol. 2005;80:207-212.
8. Yoshiba F, Hagihara M, Tazume K, et al. Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, - activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting. Bone Marrow Transplant. 2003;32:107-110.
9. Uehara T, Nakaseko C, Hara S, et al. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection. Am J Hematol. 2004;76:368-372.
10. Sakata N, Sato E, Sawada A, Yasui M, Inoue M, Kawa K. Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation [in Japanese]. Rinsho Ketsueki. 2004;45:393-396.